Wellington Management Group
DNLI icon

Wellington Management Group’s Denali Therapeutics DNLI Stock Holding History

Wellington Management Group’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
52,618
-745
-1% -$15.3K ﹤0.01% 1700
2026
Q1 		$1.02M Sell
53,363
-1,180
-2% -$23.5K ﹤0.01% 1667
2025
Q4 		$901K Sell
54,543
-4,691
-8% -$79.2K ﹤0.01% 1731
2025
Q3 		$860K Sell
59,234
-5,605,499
-99% -$80.5M ﹤0.01% 1805
2025
Q2 		$79.2M Sell
5,664,733
-5,744,865
-50% -$80.9M 0.01% 586
2025
Q1 		$155M Buy
11,409,598
+1,561,647
+16% +$29.9M 0.03% 413
2024
Q4 		$201M Sell
9,847,951
-879,499
-8% -$22.5M 0.04% 367
2024
Q3 		$312M Buy
10,727,450
+903,683
+9% +$22.4M 0.05% 296
2024
Q2 		$228M Buy
9,823,767
+1,553,818
+19% +$29.8M 0.04% 349
2024
Q1 		$170M Buy
8,269,949
+995,232
+14% +$18.7M 0.03% 422
2023
Q4 		$156M Sell
7,274,717
-14,243
-0.2% -$282K 0.03% 447
2023
Q3 		$150M Buy
7,288,960
+250,784
+4% +$6.36M 0.03% 436
2023
Q2 		$208M Buy
7,038,176
+1,837,716
+35% +$51.7M 0.04% 380
2023
Q1 		$120M Buy
5,200,460
+78,730
+2% +$2.17M 0.02% 501
2022
Q4 		$142M Buy
5,121,730
+5,100,036
+23,509% +$152M 0.03% 455
2022
Q3 		$666K Buy
+21,694
New +$705K ﹤0.01% 1725
2018
Q1 		– Sell
-14,558
Closed -$228K – 2219
2017
Q4 		$228K Buy
+14,558
New +$262K ﹤0.01% 2168

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group's DNLI Position: Q2 2026 in Review

Wellington Management Group reduced its Denali Therapeutics (DNLI) stake by 1.4% in Q2 2026, selling an estimated $15.3K and leaving 52,618 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Wellington Management Group first reported a position in DNLI in Q4 2017 and has held it in 17 quarters since. The position peaked at $312M in Q3 2024. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Wellington Management Group held 52,618 shares of Denali Therapeutics worth $1.35M as of Q2 2026.
  • Wellington Management Group sold 745 Denali Therapeutics shares in Q2 2026, an estimated $15.3K.
  • Denali Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1700 holding.
  • Wellington Management Group first reported a position in Denali Therapeutics in Q4 2017 and has held it in 17 quarters since.
  • Wellington Management Group's Denali Therapeutics position peaked at $312M in Q3 2024.
  • 294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.